Trials / Completed
CompletedNCT00152035
Safety of SPD465 in Treating Adults With ADHD.
A Phase III, Multi-center, 12-month, Open-label Safety Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 505 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and effectiveness of SPD465 in the treatment of ADHD. The study will also look at how SPD465 affects sleep.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neutral salts of dextroamphetamine sulfate, USP, amphetamine sulfate, USP, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate. |
Timeline
- Start date
- 2005-03-10
- Primary completion
- 2006-11-07
- Completion
- 2006-11-07
- First posted
- 2005-09-09
- Last updated
- 2021-08-23
Source: ClinicalTrials.gov record NCT00152035. Inclusion in this directory is not an endorsement.